147 related articles for article (PubMed ID: 1489006)
21. Worsening of left ventricular diastolic function during long-term correction of anemia with erythropoietin in chronic hemodialysis patients--an assessment by radionuclide ventriculography at rest and exercise.
Topuzović N
Int J Card Imaging; 1999 Jun; 15(3):233-9. PubMed ID: 10472525
[TBL] [Abstract][Full Text] [Related]
22. Improvement in exercise capacity after correction of anemia in patients with end-stage renal failure.
Metra M; Cannella G; La Canna G; Guaini T; Sandrini M; Gaggiotti M; Movilli E; Dei Cas L
Am J Cardiol; 1991 Oct; 68(10):1060-6. PubMed ID: 1927920
[TBL] [Abstract][Full Text] [Related]
23. Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients.
Taylor JE; Peat N; Porter C; Morgan AG
Nephrol Dial Transplant; 1996 Jun; 11(6):1079-83. PubMed ID: 8671972
[TBL] [Abstract][Full Text] [Related]
24. Correction of renal anaemia by recombinant human erythropoietin: effects on myocardial function.
Grützmacher P; Scheuermann E; Löw I; Bergmann M; Rauber K; Baum R; Heuser J; Schoeppe W
Contrib Nephrol; 1988; 66():176-84. PubMed ID: 3292146
[No Abstract] [Full Text] [Related]
25. [Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients].
Jacquot C; Berthelot JM; Chiappini-Judith D; Ferragu-Haguet M; Lefebvre A; Masselot JP; Moynot A; Frydman MO; Peterlongo F
Nephrologie; 1990; 11(1):11-6. PubMed ID: 2374641
[TBL] [Abstract][Full Text] [Related]
26. Monitoring erythropoietin therapy for anaemia of chronic renal failure by serum erythropoietin assays.
Marsden JT; Sherwood RA; Hillis A; Peters TJ
Ann Clin Biochem; 1993 Mar; 30 ( Pt 2)():205-6. PubMed ID: 8466156
[No Abstract] [Full Text] [Related]
27. [Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience].
de Sousa FT; Prata MM; Barbas JV; dos Santos JP
Acta Med Port; 1990; 3(6):347-52. PubMed ID: 2089856
[TBL] [Abstract][Full Text] [Related]
28. Effect of treatment of anaemia with erythropoietin on neuromuscular function in patients on long term haemodialysis.
Sobh MA; el-Tantawy AE; Said E; Atta MG; Refaie A; Nagati M; Ghoneim M
Scand J Urol Nephrol; 1992; 26(1):65-9. PubMed ID: 1631509
[TBL] [Abstract][Full Text] [Related]
29. The quality of life of dialysis patients treated with recombinant human erythropoietin.
Auer J; Oliver DO; Winearls CG
Scand J Urol Nephrol Suppl; 1990; 131():61-5. PubMed ID: 2075472
[TBL] [Abstract][Full Text] [Related]
30. Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.
Hussein MM; Mooij JM; Roujouleh H
Nephrol Dial Transplant; 1994; 9(7):876-7. PubMed ID: 7818713
[No Abstract] [Full Text] [Related]
31. Exercise tolerance after anaemia correction with recombinant human erythropoietin in end-stage renal disease.
Baraldi E; Montini G; Zanconato S; Zacchello G; Zacchello F
Pediatr Nephrol; 1990 Nov; 4(6):623-6. PubMed ID: 2128459
[TBL] [Abstract][Full Text] [Related]
32. [Current issues in erythropoietin therapy of renal anemia].
Zakar G
Lege Artis Med; 2007 Oct; 17(10):667-73. PubMed ID: 19227596
[TBL] [Abstract][Full Text] [Related]
33. Recombinant human erythropoietin for the treatment of renal anaemia in children: no justification for bodyweight-adjusted dosage.
Port RE; Kiepe D; Van Guilder M; Jelliffe RW; Mehls O
Clin Pharmacokinet; 2004; 43(1):57-70. PubMed ID: 14715051
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of improved physical performance of chronic hemodialysis patients after erythropoietin treatment.
Grunze M; Kohlmann M; Mulligan M; Grüner I; Koeppel M; Bommer J
Am J Nephrol; 1990; 10 Suppl 2():15-8; discussion 18-23. PubMed ID: 2124412
[TBL] [Abstract][Full Text] [Related]
35. [The treatment of anemia in patients on hemodialysis with recombinant human erythropoietin].
Borrego FJ; Miguel JL; Zamorano A; Muñoz J; Bajo A; López-Revuelta K; Sánchez Sicilia L
Med Clin (Barc); 1991 Nov; 97(18):687-92. PubMed ID: 1770818
[TBL] [Abstract][Full Text] [Related]
36. UK Renal Registry 16th annual report: chapter 10 haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2012: national and centre-specific analyses.
Rao A; Gilg J; Williams A
Nephron Clin Pract; 2013; 125(1-4):183-208. PubMed ID: 24662174
[TBL] [Abstract][Full Text] [Related]
37. Androgen therapy for anaemia of chronic renal failure. Indications in the erythropoietin era.
Teruel JL; Aguilera A; Marcen R; Navarro Antolin J; Garcia Otero G; Ortuño J
Scand J Urol Nephrol; 1996 Oct; 30(5):403-8. PubMed ID: 8936631
[TBL] [Abstract][Full Text] [Related]
38. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.
Ramírez B; Flores A; Pérez F; Córdoba C; García L; Vázquez G
Transplant Proc; 1991 Apr; 23(2):1833-4. PubMed ID: 2053170
[No Abstract] [Full Text] [Related]
39. Effect on hemoglobin F synthesis by erythropoietin in patients with anemia of end-stage renal disease maintained by chronic hemodialysis.
Salvati F; Strippoli P; Barchetti M; Scatizzi A
Nephron; 1992; 60(3):371. PubMed ID: 1373475
[No Abstract] [Full Text] [Related]
40. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
